Location History:
- Huningue, FR (2005)
- St. Louis, FR (2007 - 2010)
Company Filing History:
Years Active: 2005-2010
Title: The Innovative Contributions of Daniel Hoyer
Introduction
Daniel Hoyer is a notable inventor based in St. Louis, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target somatostatin receptors. With a total of 3 patents to his name, Hoyer's work has the potential to impact the treatment of various mental health disorders.
Latest Patents
Hoyer's latest patents include innovative compounds that serve as somatostatin SST1 receptor antagonists. One of his notable inventions is a compound of the formula (I), wherein R, R, n, and m are defined in the specification. These compounds are designed to act as somatostatin SST1 receptor antagonists. Another significant patent involves piperazine derivatives that exhibit SST1 antagonistic activity. This invention provides compounds of a specific formula, wherein X, R, and R are defined in the specification, along with their preparation and use in treating conditions such as depression, anxiety, and bipolar disorders.
Career Highlights
Throughout his career, Daniel Hoyer has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis Pharma GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Hoyer has collaborated with several professionals in his field, including Thomas Josef Troxler and Konstanze Hurth. These collaborations have likely enriched his research and development efforts, fostering a creative environment for innovation.
Conclusion
Daniel Hoyer's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of mental health disorders.